Related Experiment Video
Updated: May 20, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future
Runxing Lin1, Ziyu Huang1, Yu Liu1
1Joint Key Laboratory of the Ministry of Education, Institute of Applied Physics and Materials Engineering, University of Macau, Avenida da Universidade, Taipa 999078, Macau.
Insights
Personalized cardiovascular drug therapy addresses individual variability in treating heart disease. This review explores dynamic monitoring and data analysis strategies for tailored treatments.
Area of Science:
- Cardiology
- Pharmacogenomics
- Biomedical Engineering
Background:
- Cardiovascular diseases (CVDs) pose significant global health challenges.
- Individual variability in patient response complicates effective CVD treatment.
- Personalized medicine offers a promising approach to optimize cardiovascular drug therapy.
Purpose of the Study:
- To review strategies for personalized cardiovascular drug therapy.
- To examine dynamic monitoring and multidimensional data analysis techniques.
- To identify current challenges and future research directions in the field.
Main Methods:
- Systematic literature review of personalized cardiovascular drug therapy.
- Analysis of traditional dynamic monitoring technologies.
- Evaluation of multidimensional data integration and analysis approaches.
Main Results:
- Dynamic monitoring and data integration are key to personalized CVD treatment.
- Individual differences necessitate tailored monitoring and analysis strategies.
- Current research faces challenges in implementing these personalized approaches.
Conclusions:
- Personalized cardiovascular drug therapy requires advanced monitoring and data analysis.
- Future research should focus on overcoming implementation challenges.
- Tailoring treatments to individual variability is crucial for improving CVD outcomes.
Abstract:
Cardiovascular diseases have long been a major challenge to human health, and the treatment differences caused by individual variability remain unresolved. In recent years, personalized cardiovascular drug therapy has attracted widespread attention. This paper reviews the strategies for achieving personalized cardiovascular drug therapy through traditional dynamic monitoring and multidimensional data integration and analysis. It focuses on key technologies for dynamic monitoring, dynamic monitoring based on individual differences, and multidimensional data integration and analysis. By systematically reviewing the relevant literature, the main challenges in current research and the proposed potential directions for future studies were summarized.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Errors occurring during blood pressure monitoring
Several factors...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

